IP Library Granted Patent US 8,431,415
Granted Patent B2
US 8,431,415 · App. 12/509,895 · Granted Apr 30, 2013

Immunoassay using insoluble carrier particles and reagent therefor

Inventor: Kayoko Shigenobu (Shizuoka, JP)
Assignee: TFB, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,431,415
App. No.
12/509,895
Granted
Apr 30, 2013
Kind
B2
Abstract

The present invention provides a reagent for an immunoassay comprising insoluble carrier particles which can give the values to be determined with high accuracy and reliability, and can be stored for a long time; an immunoassay using the reagent; and a method for keeping the reagent stable. The present invention provides an immunoassay which comprises carrying out an antigen-antibody reaction using insoluble carrier particles in an aqueous medium comprising a buffer having its buffer capacity in a neutral or alkaline region (except for a carbonate-based buffer) and a carbonic acid compound releasing a bicarbonate ion; a reagent for an immunoassay comprising a buffer having its buffer capacity in a neutral or alkaline region (except for a carbonate-based buffer), a carbonic acid compound releasing bicarbonate ion, and insoluble carrier particles; and a method for keeping the reagent for an immunoassay comprising insoluble carrier particles stable, which comprises allowing insoluble carrier particles to co-exist in an aqueous medium comprising a buffer having its buffer capacity in a neutral or alkaline region (except for a carbonate-based buffer) and a carbonic acid compound releasing a bicarbonate ion.

Claims (11)

1. A nephelometric immunoassay, which comprises the steps of:

1) preparing a suspension by adding insoluble carrier particles carrying neither a substance to be determined nor antibodies to the substance to an aqueous medium consisting essentially of a buffer having its buffer capacity in a neutral or alkaline region except for a carbonate-based buffer and a carbonic acid compound releasing a bicarbonate ion;

2) keeping the suspension of step 1);

3) reacting the suspension comprising the insoluble carrier particles with a sample comprising substance to be determined;

4) adding a reagent comprising antibodies reactive with the substance to be determined to the mixture of step 3); and

5) measuring agglutination of insoluble carrier particles formed in step 4).

2. The immunoassay according to claim 1 , wherein the substance to be determined is hemoglobin A1c.

3. The immunoassay according to claim 1 , wherein the carbonic acid compound releasing a bicarbonate ion is an alkali metal compound.

4. The immunoassay according to claim 1 , wherein the concentration of the bicarbonate ion is 0.05 to 500 mmol/L.

5. The immunoassay according to claim 1 , wherein the concentration of the buffer having its buffer capacity in a neutral or alkaline region is 0.1 to 500 mmol/L.

6. The immunoassay according to claim 1 , wherein the insoluble carrier particles are latex.

Assignments (4)
MERGER Recorded Jun 23, 2014
From: TFB, INC.
To: FUJIREBIO INC.
Reel/Frame 033156/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2013
From: SHIGENOBU, KAYOKO
To: KYOWA MEDEX CO., LTD.; TFB, INC.
Reel/Frame 030469/0369 →
CHANGE OF ASSIGNEE ADDRESS Recorded Feb 28, 2013
From: SRL, INC.
To: TFB, INC
Reel/Frame 029895/0153 →
CHANGE OF OWNERSHIP DUE TO DEMERGER Recorded May 14, 2010
From: SRL, INC.
To: TFB, INC.
Reel/Frame 024388/0297 →
Priority Claims (1)
JP 2000-226805 · Jul 27, 2000 · national
Continuity (2)
Division 10333785
Related Publication 20090286330A1 · Nov 19, 2009